Covered recipient · General Payments record
HAZEM ABDEL-HAFEEZ AL-ASHHAB
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$93,172.20
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $726.23 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $288.17 | 15 |
| Acerta Pharma LLC | $125.00 | 1 |
| Olympus America Inc. | $89.90 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $53.64 | 3 |
| PFIZER INC. | $43.38 | 2 |
| Celgene Corporation | $40.68 | 2 |
| Ardelyx, Inc. | $32.75 | 2 |
| Celltrion USA Inc. | $20.93 | 1 |
| Merck Sharp & Dohme Corporation | $18.27 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $13.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212022
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.56 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246091 | CMS |
| ABBVIE INC. | $6.15 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246093 | CMS |
| ABBVIE INC. | $24.27 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246095 | CMS |
| ABBVIE INC. | $6.14 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246097 | CMS |
| ABBVIE INC. | $28.22 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246099 | CMS |
| ABBVIE INC. | $2.01 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246101 | CMS |
| ABBVIE INC. | $18.26 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246103 | CMS |
| ABBVIE INC. | $2.63 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246105 | CMS |
| ABBVIE INC. | $3.20 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246107 | CMS |
| ABBVIE INC. | $4.26 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246109 | CMS |
| ABBVIE INC. | $15.39 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246111 | CMS |
| ABBVIE INC. | $7.07 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246113 | CMS |
| ABBVIE INC. | $17.29 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246115 | CMS |
| ABBVIE INC. | $124.46 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246117 | CMS |
| ABBVIE INC. | $24.26 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103246119 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.95 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146959913 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $20.54 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146974719 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.15 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147002872 | CMS |
| Ardelyx, Inc. | $14.15 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146669575 | CMS |
| Ardelyx, Inc. | $18.60 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146669577 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105769344 | CMS |
| Celgene Corporation | $18.42 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101147493 | CMS |
| Celgene Corporation | $22.26 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101147497 | CMS |
| Celltrion USA Inc. | $20.93 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075848441 | CMS |
| Intercept Pharmaceuticals, Inc. | $13.51 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113634488 | CMS |
| Merck Sharp & Dohme LLC | $18.27 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141692946 | CMS |
| Olympus America Inc. | $89.90 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108485234 | CMS |
| PFIZER INC. | $24.75 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131453675 | CMS |
| PFIZER INC. | $18.63 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131580640 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.